Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies. To accomplish this mission, we are dedicated to achieving these goals in Washington, D.C. and across the country.

Featured Blogs

In the current health care debate, Congress has lost sight of what matters to U.S. voters

Debra DeShong
Beyond failing to address the broader drivers of affordability challenges, government price-setting policies like that in the Build Back Better plan are not even what voters want.

Making Medicines More Affordable: PhRMA’s solutions

Emilie Signora
We are in a new era of medicine where breakthrough science is transforming patient care, but these innovations are meaningless if patients can’t afford them.

Understanding breakthrough COVID-19 infections

Richard Moscicki, M.D.
Here are a few common questions about breakthrough COVID-19 infections.